WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997022334) PGE-1 CONTAINING LYOPHILIZED LIPOSOMES FOR USE IN THE TREATMENT OF ERECTILE DYSFUNCTION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/022334    International Application No.:    PCT/US1996/018820
Publication Date: 26.06.1997 International Filing Date: 26.11.1996
Chapter 2 Demand Filed:    15.07.1997    
IPC:
A61K 9/00 (2006.01), A61K 9/127 (2006.01), A61K 31/5575 (2006.01)
Applicants: HARVARD SCIENTIFIC CORPORATION [US/US]; Suite 18, 1601 East Flamingo, Las Vegas, NV 89119 (US)
Inventors: SEE, Jackie, R.; (US)
Agent: DILLARD, David, A.; Christie, Parker & Hale, L.L.P., P.O. Box 7068, Pasadena, CA 91109-7068 (US)
Priority Data:
08/573,408 15.12.1995 US
Title (EN) PGE-1 CONTAINING LYOPHILIZED LIPOSOMES FOR USE IN THE TREATMENT OF ERECTILE DYSFUNCTION
(FR) LIPOSOMES LYOPHILISES CONTENANT DE LA PGE-1 POUR LE TRAITEMENT DES TROUBLES DE L'ERECTION
Abstract: front page image
(EN)A method for the treatment of erectile dysfunction comprises instilling intra meatally an aqueous solution containing prostaglandin containing liposomes and a detergent for lysing the liposomes. A pharmaceutical composition for treating erectile dysfunction comprises a two component system. The first component comprises a predetermined amount of lyophilized prostaglandin containing liposomes. The second component comprises a predetermined volume of an aqueous solution containing a detergent for lysing the liposomes. Dissolution of the lyophilized prostaglandin containing liposomes yields a liquid composition suitable for application to the penis, to effect erection.
(FR)L'invention porte sur un traitement des troubles de l'érection consistant à injecter par le méat une solution aqueuse de liposomes contenant de la prostaglandine associée à un détergent de lyse des liposomes. Elle porte également sur une composition pharmaceutique de traitement desdits troubles consistant en un système à deux composants dont le premier est une quantité donnée de liposomes contenant de la prostaglandine lyophilisée et le second, une solution aqueuse de détergent de lyse des liposomes. La dissolution des liposomes contenant de la prostaglandine lyophilisée donne une composition liquide qui, appliquée au pénis, produit l'érection.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, UZ, VN.
African Regional Intellectual Property Organization (KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)